Title : Lenalidomide in DLBCL: are we past the cell of origin?

Pub. Date : 2021 May

PMID : 33989279






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 However, the addition of lenalidomide to rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) in randomized clinical trials has shown equivocal benefit, despite phase 2 studies that suggested otherwise. Lenalidomide DNA damage inducible transcript 3 Homo sapiens